Can Migraines Go Away for Years and Come Back?

Yes. Migraines can disappear for years and then return, and this pattern is common rather than unusual. Roughly 20 to 30 percent of people with migraine experience extended remission, often during their 30s to 50s, and a meaningful share eventually have attacks again. The mechanism is a shift in brain-state thresholds, not a cure that failed. Hormonal changes, sleep disruption, new stressors, and medication patterns can lower the trigger threshold years later. A return of attacks after a long quiet stretch is a recognized clinical pattern, not a sign that the earlier diagnosis was wrong.

The Biology of a Migraine That Goes Quiet

A migraine attack starts in a brain that is already primed. People with migraine have a lower threshold for a wave of neuronal and vascular activation in the trigeminovascular system, the nerve-and-blood-vessel network that produces throbbing pain. Between attacks, that threshold can sit high enough that ordinary triggers, a skipped meal, a poor night's sleep, a glass of red wine, do nothing.

Remission means the threshold has risen. The brain still carries the same genetic and structural predisposition, but the margin between daily life and an attack has widened. Attacks stop when that margin stays wide for months.

In plain terms: the migraine machinery is dormant, not dismantled. The vulnerability remains coded in the nervous system, which is why a return is possible decades later.

The key variable is central sensitization, the process by which repeated stimulation makes pain pathways hyperexcitable. When sensitization resolves, the trigeminovascular system becomes less reactive. It can re-sensitize if the conditions that originally primed it return. The 2018 International Classification of Headache Disorders, third edition (ICHD-3), recognizes this by classifying migraine as an episodic or chronic disorder that can change category over a lifetime, not a fixed state.

One non-obvious point: the return of attacks is often triggered by a cluster of small changes rather than one dramatic event. A new job with irregular hours, a shift in hormonal status, and a change in caffeine intake can stack. Each alone might not cross the threshold; together they do.

How Common Is Remission, and How Often Does It Return?

The numbers matter because they set realistic expectations. Longitudinal headache studies put the one-year remission rate for episodic migraine in the range of 2 to 8 percent per year, meaning most people do not simply "outgrow" it. Over a decade, however, cumulative remission climbs substantially.

These ranges come from population and clinic cohorts and vary by study design. The consistent finding is this: remission is common, and relapse is common too. Roughly a third of people who go quiet for years will eventually have another attack, often milder than before.

The single most useful comparison a reader can hold: a 20 percent five-year relapse risk means that after a multi-year quiet period, about one in five people will see attacks again. That is high enough to plan around and low enough that it should not dominate daily life.

Reconcile the thresholds plainly: remission is defined as no attacks for 12 months, while sustained remission usually means three or more attack-free years; relapse risk is highest in the first 2 years after remission and then falls.

The Timeline of Remission and Return

Migraine tends to follow a life-course arc. Tracking it on a timeline makes the "goes away and comes back" pattern easier to understand.

The table shows that the "quiet years" most often fall in the late 50s and 60s. That is also when a return can surprise people who assumed they were finished. Per the Migraine Research Foundation's long-running patient surveys, remission is most durable when it begins after age 55 and least durable when it begins in the 30s.

Why Attacks Return: The Mechanism of Relapse

Relapse is not a random event. Four mechanisms explain most returns, and each carries its own numbers.

Hormonal shifts are the leading cause in women. Estrogen withdrawal, whether at perimenopause, after stopping hormonal contraception, or after pregnancy, is one of the best-documented migraine triggers. A drop of estrogen in the late luteal phase is associated with a 1.5 to 2 times higher attack risk in susceptible women. Perimenopause, which lasts an average of 4 to 7 years, often brings a temporary worsening before improvement.

Central sensitization reversal is the second. Even years after attacks stop, pain pathways can remain mildly primed. A new injury, illness, or period of poor sleep can re-establish sensitization. The 2019 American Headache Society consensus notes that patients with a history of chronic migraine carry a higher relapse risk than those who only ever had episodic attacks.

Medication patterns matter more than most people expect. Overuse of acute pain relievers can convert a quiet pattern into a rebound cycle. Using simple analgesics on 15 or more days a month, or triptans on 10 or more days a month, is the standard overuse threshold. A person who had years of remission and then begins treating frequent tension headaches with daily ibuprofen can tip back into migraine.

Life-stage stressors complete the list. Sleep disruption, weight change, and sustained psychological stress all lower the threshold. None of these "cause" migraine in someone without the predisposition, but in a person with a dormant history they can reactivate it.

Migraine With and Without Aura: Different Remission Odds

The two main migraine types behave differently over a lifetime, and the distinction matters for anyone tracking a return.

Migraine with aura carries a somewhat higher persistence rate. Aura symptoms, visual zigzags, tingling, or speech changes, tend to continue later in life even when the headache phase fades. Some people who report "silent" years actually had aura-only episodes they did not count as migraines.

This is a corrected misconception worth stating directly: "my migraines are gone" often means "my headaches are gone," not "my aura is gone." If visual or sensory aura persists during a quiet stretch, the underlying condition has not fully remitted. A 2020 review in the journal Neurology found that aura can persist for 10 or more years after headache remission in about a quarter of people with migraine with aura.

Common Misconceptions About Returning Migraines

Several beliefs about remission are inaccurate and lead to poor decisions. Correcting them changes how people plan.

The first misconception is that a long remission means a misdiagnosis. It does not. Migraine is defined by its attack pattern, and an attack pattern that changes over decades is expected. A person diagnosed at 25 and symptom-free from 40 to 60 was not misdiagnosed; the disorder went quiet.

The second is that a return always means a new, worse disease. In most cases a return is the same migraine pattern reactivated. The 2018 ICHD-3 criteria do not require continuous attacks for a diagnosis to stand. A return after years is a recurrence, not a new condition.

The third is that migraines always worsen with age. The data show the opposite for most people. Prevalence peaks in the 30s and 40s and falls afterward. Under 10 percent of people still have frequent attacks past age 60.

The fourth is that remission can be forced by a single intervention. Diets, supplements, and lifestyle changes help at the margins, but no single intervention reliably produces permanent remission. The 2021 American Headache Society guideline on preventive treatment recommends preventive medication for people with 4 or more headache days a month, but even effective prevention is a management tool, not a cure.

A professional caveat: remission is a change in attack frequency, not proof the trigeminovascular system has normalized. Brain imaging studies in people with long remission still show altered pain-processing responses to experimental stimuli, which is why relapse remains possible.

What to Actually Do When Migraines Return

A returning migraine pattern is manageable. The right actions fall into a clear sequence.

Track before treating. Keep a headache diary for at least 4 weeks. Record attack dates, duration, severity, suspected triggers, and every medication taken with the day count. This diary is what distinguishes a true migraine return from a cluster of tension headaches or medication overuse.

See a clinician who knows the history. Bring the diary and the dates of the earlier remission. A neurologist or headache specialist can confirm the diagnosis and check for secondary causes. Per the 2019 American Headache Society consensus, a return after age 50 warrants a review for new secondary headaches, including vascular causes.

Rebuild the prevention foundation. Regular sleep, consistent meals, hydration, and moderate caffeine are low-cost and evidence-supported. If attacks reach 4 or more headache days a month, preventive treatment is reasonable. Options include beta-blockers, topiramate, and CGRP monoclonal antibodies. The CGRP antibodies, introduced from 2018 onward, have response rates of roughly 50 percent at 12 weeks in trials.

Watch for red flags. A return of migraine is expected; the warning signs below are not. Seek urgent care for any of these:

• The worst headache of your life, or a sudden "thunderclap" onset
• New weakness, numbness, or speech difficulty that does not resolve
• Fever with a stiff neck or a new rash
• A new headache pattern after age 50
• Headache that worsens with coughing, straining, or position change
• New visual loss or double vision

Avoid medication overuse. Cap simple analgesics at fewer than 15 days a month and triptans at fewer than 10 days a month. Track this in the diary. Overuse is the most common reversible cause of a returning pattern.

Plan for the long view. If remission was durable once, it can be durable again. The 2021 American Headache Society guidance supports stepping down preventive treatment after 6 to 12 months of good control, with monitoring for relapse.

Limits of the Evidence

The remission-and-relapse picture is well described, but several gaps remain. Most longitudinal studies rely on self-report and clinic samples, which can overstate remission in people who stop seeking care. Relapse rates are estimated from cohorts that may not represent the general population, so the 20 to 40 percent figure should be read as a range, not a fixed risk.

The biology of why some people remit and others do not is still partly hypothesis. Genetic factors, particularly variants in genes such as CACNA1A and ATP1A2, are linked to rare familial forms, but common migraine genetics explain only part of the variance. The role of central sensitization in relapse is supported by experimental pain studies, yet no biomarker currently predicts who will relapse.

What is established: migraine is a lifelong predisposition that can go quiet for years and return. What is not: a reliable way to predict, for any one person, whether and when attacks will come back. That uncertainty is the reason a headache diary and a clinician who knows the history are the two most valuable tools a person with a returning migraine can have.